KeyBanc Downgrades DaVita To Hold

By: via Benzinga
Analysts at KeyBanc downgraded DaVita HealthCare Partners (NYSE: DVA) from Buy to Hold and removed the target price of $75. DaVita ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.